[Blood cell counts in parenteral drug addicts]. 1987

E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru

UI MeSH Term Description Entries
D008297 Male Males
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D004906 Erythrocyte Count The number of RED BLOOD CELLS per unit volume in a sample of venous BLOOD. Blood Cell Count, Red,Erythrocyte Number,Red Blood Cell Count,Count, Erythrocyte,Counts, Erythrocyte,Erythrocyte Counts,Erythrocyte Numbers
D005260 Female Females
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru
January 1985, JAMA,
E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru
January 1989, Enfermedades infecciosas y microbiologia clinica,
E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru
January 1986, Scandinavian journal of infectious diseases,
E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru
January 1986, Medicina clinica,
E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru
July 1986, Medicina clinica,
E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru
December 1995, Revista clinica espanola,
E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru
January 1995, Revista clinica espanola,
E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru
February 1994, Revista clinica espanola,
E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru
March 1999, Revista clinica espanola,
E Aguilar Ligorit, and J Guix García, and I Ample Guillén, and V Escrig Orenga, and A Pascual López, and V Alberola Candel, and J García-Conde Bru
February 1989, Enfermedades infecciosas y microbiologia clinica,
Copied contents to your clipboard!